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Abstract
Background: The predominant sterol in the membranes of the alga Chlamydomonas reinhardtii is ergosterol, which is
commonly found in the membranes of fungi, but is rarely found in higher plants. Higher plants and fungi synthesize sterols
by different pathways, with plants producing cycloartenol as a precursor to end-product sterols, while non-
photosynthesizing organisms like yeast and humans produce lanosterol as a precursor. Analysis of the C. reinhardtii
genome sequence reveals that this algae is also likely to synthesize sterols using a pathway resembling the higher plant
pathway, indicating that its sterols are synthesized somewhat differently than in fungi. The work presented here seeks to
establish experimental evidence to support the annotated molecular function of one of the sterol biosynthetic genes in the
Chlamydomonas genome.
Methodology/Principal Findings: A gene with homology to the yeast sterol C-5 desaturase, ERG3, is present in the
Chlamydomonas genome. To test whether the ERG3 ortholog of C. reinhardtii encodes a sterol C-5 desaturase,
Saccharomyces cerevisiae ERG3 knockout strains were created and complemented with a plasmid expressing the
Chlamydomonas ERG3. Expression of C. reinhardtii ERG3 cDNA in erg3 null yeast was able to restore ergosterol biosynthesis
and reverse phenotypes associated with lack of ERG3 function.
Conclusions/Significance: Complementation of the yeast erg3 null phenotypes strongly suggests that the gene annotated
as ERG3 in C. reinhardtii functions as a sterol C-5 desaturase.
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Introduction
Sterols are isoprenoid-derived molecules found in the mem-
branes of eukaryotic organisms and have been shown to play an
important role in membrane fluidity and permeability [1–4].
While sterols are essential components of eukaryotic membranes,
the specific sterols found in different organisms vary [5].
Cholesterol is the predominant sterol in vertebrates and ergosterol
is the most common sterol found in fungi. Plants have a variety
of sterols including sitosterol, 24-methyl cholesterol and stigmas-
terol [6].
Two major pathways for sterol biosynthesis have been found in
eukaryotes. Fungi and vertebrates synthesize sterols with lanosterol
as an intermediate (Fig. 1), while plants synthesize sterols using
cycloartenol as an intermediate [5]. In these pathways the
biosynthetic steps from isopentanyl PP to squalene epoxide are
the same. However, the cyclization of squalene epoxide is where
the two pathways diverge producing either cycloartenol or
lanosterol [7]. Nes et al., have identified cycloartenol in fungal-
like organisms Prototheca wickerhamii and Dictyostelium discoidium
that have been presumed to be descendents of algae after the
evolutionary loss of the chloroplast [8]. It is now scientifically
accepted that red algae, green algae and diatoms make
cycloartenol while dinoflagellates have been reported to make
lanosterol [9,10].
In the green alga C. reinhardtii, the predominant sterols are
ergosterol and 7-dehydroporiferasterol [11]. These two sterols are
commonly found in fungi, but not so often with higher plants.
However, bioinformatics evidence supports the idea that C.
reinhardtii uses the cycloartenol pathway, as genes coding for
orthologs of cycloartenol cyclase and cyclopropyl isomerase, two
key enzymes in the cycloartenol pathway, are found in the C.
reinhardtii genome [12] (Brumfield and Moroney, unpublished
results). So while C. reinhardtii synthesizes ergosterol, a sterol
normally associated with the fungal biosynthetic pathway, it
appears to use a pathway that more closely resembles that of
higher plants. Earlier studies of ergosterol deficient mutants in C.
reinhardtii provide evidence for the final few steps of ergosterol
biosynthesis in this alga [13,14]. However, the steps from squalene
epoxide to ergosta- 5,7,24 (28)-trienol have not been determined.
A goal of this work is to further elucidate the sterol biosynthetic
pathway in C. reinhardtii.
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8659With the publication of the Chlamydomonas genome, genes likely to
be associated with sterol biosynthesis in C. reinhardtii can be identified
[12]. While C. reinhardtii offers many advantages as an experimental
organism, it is still difficult to obtain targeted knock-out mutants of a
desiredgene.Inaddition,thefactthatmutantsearlierinthepathway
have not been identified implies that a complete loss of sterol might
be lethal to the alga under normal growth conditions. An alternative
approach is to use Sacchromyces cerevisiae to study the function of genes
involved in sterol biosynthesis in C. reinhardtii. The post-squalene
biosynthesis pathway of ergosterol in yeast has been well defined
[15,16]. Enzymes of the ergosterol biosynthetic pathway have been
found to be major targets for drug interactions, and a number of
antifungal drugs on the market were derived specifically to target
ergosterol biosynthesis [17–19]. Much of what is known about the
sterol pathway in Arabidopsis has been worked out by complementing
yeast strains defective in specific steps of sterol biosynthesis with the
Arabidopsis ortholog [20]. We have previously used this approach to
study phospholipid biosynthesis in C. reinhardtii [21,22].
One gene essential to ergosterol biosynthesis is ERG3, which
encodes the C-5 sterol desaturase responsible for introducing a
double bond at C-5 in the B ring of episterol [23] (Fig. 2). This
enzyme is sensitive to cyanide and requires iron as well as
molecular oxygen for its activity [15]. ERG3 in yeast is also
associated with NAD(P)H-cytochrome b/cytochrome b5 [23]. It
has been previously demonstrated that ERG3 is required for the
breakdown of respiratory substrates when cells are heme deficient
[24]. Deletion of ERG3 in S. cerevisiae produces haploid cells that
overaccumulate the ergosterol precursor, episterol [25]. Episterol
and ergosta-7, 22-dien- 3-beta-ol are reported as possible
substrates for the C-5 sterol desaturase [26]. Cloning and
sequencing of ERG3 has been reported in several model systems
including Arabidopsis thaliana [27] and Homo sapiens [28]. In yeast,
ERG3 is a non-essential gene except under environments of heme-
deficiency [24]. It has been suggested that Erg3 protein is a critical
target in ergosterol biosynthesis [29], and when other ergosterol
biosynthetic enzymes are mutated, ERG3 expression is directly
affected and regulated by these mutations [15].
In this study, we begin to characterize the function of ERG3 in
C. reinhardtii by complementation in S. cerevisiae ergosterol mutants.
Questions remain as to whether algae produce sterols for other
purposes, such as hormonal regulators [30], or if they function
strictly for membrane integrity. Understanding the dynamics of
this pathway may provide further evidence for hormonal
regulation in C. reinhardtii, and the important cellular functions
that may arise from the production of these sterols and their
biosynthetic precursors.
Results
Sequence Analysis of the ERG3 Gene
A comparison of the Saccharomyces cerevisiae ERG3 to the
Chlamydomonas genome revealed several genes with significant
Figure 1. Schematic diagram of the putative pathway of ergosterol biosynthesis in S. cerevisiae and C. reinhardtii.
doi:10.1371/journal.pone.0008659.g001
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had a 21% sequence identity to the ERG3 sterol desaturase of
yeast. This Chlamydomonas gene also had a high similarity to ERG3
genes annotated in higher plants. The gene with the next highest
homology had a sequence identity of only 16%, and appears to be
more closely related to the sequence of the yeast ERG25 methyl
sterol oxidase. Based on both the higher similarity of the 21%
homologous gene to yeast and plant ERG3, and the higher
similarity of the 16% homologous gene to ERG25, we chose the
former gene for further analysis, and tentatively annotated it as
Chlamydomonas ERG3 (Accession No. XP_001701457).
In yeast, ERG3 is a C-5 sterol desaturase that adds a double
bond in the ring structure of episterol to produce in the ergosterol
biosynthetic pathway [31] (Fig. 2). In the proposed pathway for
ergosterol biosynthesis in C. reinhardtii (Fig. 1), ERG3 would
catalyze the conversion of episterol to ergosta- 5,7,24 (28)-trienol.
ERG3 in C. reinhardtii is located on chromosome 16 of the genome
[12], and the predicted amino acid sequence of ERG3 aligns well
with other C-5 sterol desaturases (Table 1 and Fig. 3). The ERG3
gene in C. reinhardtii encodes a protein of 351 amino acids [12].
The cDNA is approximately 1.1kb long and is composed of six
exons according to Version 4.0 of the Chlamydomonas Genome
[12] (Fig 4). Like other known Erg3 proteins, the homologous gene
in C. reinhardtii codes for four putative histidine metal binding
domains [28] (Fig. 3). A genome database (http://genomeportal.
jgi-psf.org/Chlre4/Chlre4.home.html) predicts that Erg3 protein
has 3 transmembrane helices. The first helix is thought to be made
up of amino acids 10–32, while the second and third helices
correspond to amino acids 110–132 and 191–213 [12,32],
respectively (Fig. 3).
Deletion of ERG3 by Homologous Recombination
While ERG3 from Chlamydomonas aligned well with putative
plant ERG3 genes (Fig. 3), its alignment with the characterized
ERG3 protein of yeast showed a lesser degree of identity and
similarity. To provide evidence that Chlamydomonas ERG3 functions
as a C-5 desaturase, we designed experiments to complement a
yeast erg3D mutant. To generate the null mutation in yeast, the
ERG3 gene was knocked out by homologous recombination and
replaced with the URA3 marker in a diploid yeast strain (Fig. 5A).
PCR analysis was used to identify positive yeast recombinants that
possessed the ERG3 mutation, and these isolates were sporulated
to obtain haploid erg3D strains (Fig. 5B). Yeast lacking a functional
ERG3 are viable, as the gene is non-essential under aerobic
conditions [33]. In addition, yeast lacking ERG3 have an increased
sensitivity to cycloheximide as previously described [34]. Haploid
isolates obtained from yeast ERG3 knockouts demonstrated
increased sensitivity to cycloheximide when grown under optimal
conditions in rich media.
Complementation of ERG3 Mutants
To test the function of the C. reinhardtii ERG3 gene, complemen-
tation experiments using yeast haploid strains deficient in ERG3
were conducted. Yeast erg3D strains display a marked hypersensi-
tivity to low non-lethal levels of cycloheximide [34]. In these
experiments, plasmids expressing the yeast ERG3 ORF, C. reinhardtii
ERG3 ORF and the empty vector were transformed into the erg3D
knockout strains(Fig. 6A and Table 2).The selectable markerLEU2
was used to select for transformants on minimal media lacking
leucine (Fig. 6A), and Leu+ isolates were then screened for
resistance to low levels of cycloheximide (Fig. 6B). Mutant erg3D
strains transformed with the pDD1193, the empty vector, remained
hypersensitive to cycloheximide, as they displayed very little growth
on plates containing the drug (Fig. 6B). Transformants containing
Figure 2. Schematic diagram of the reaction catalyzed by
Erg3p in yeast. Erg3p is responsible for introducing a double bond at
the C-5 carbon (denoted by the star) of the B-ring of episterol to
produce ergosta- 5,7,24(28)- trienol. This step is the second to last step
in the biosynthetic pathway to ergosterol.
doi:10.1371/journal.pone.0008659.g002
Table 1. Alignment scores among sterol C-5 desaturases of
various organisms generated from ClustalW.
AtERG3 ZmERG3 CrERG3 HsERG3 RnERG3 ScERG3
A t E R G 3 - 6 5 4 62 72 72 4
ZmERG3 65 - 48 24 25 24
CrERG3 46 48 - 19 19 21
HsERG3 27 24 19 - 82 43
RnERG3 27 25 19 82 - 44
ScERG3 24 24 21 43 44 -
Arabidopsis thaliana (AtERG3); Zea mays (ZmERG3); Chlamydomonas reinhardtii
(CrERG3); Homo sapiens (HsERG3); Rattus norvegicus (RnERG3); Saccharomyces
cerevisiae (ScERG3).
doi:10.1371/journal.pone.0008659.t001
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resistant to low levels of cycloheximide (Fig. 6B). Transforming the
mutants with pDD1191, expressing the C. reinhardtii ERG3 ORF,
showed enhanced resistance to the drug, demonstrating that the
algal gene could complement the loss of the yeast ERG3 (Fig. 6B).
Previous work had also reported that yeast ERG3 mutants are
viable but cannot grow on non-fermentable carbon sources
[24,33,35]. We used this phenotype as a second test of the ability
of the Chlamydomonas ERG3 to complement yeast erg3D strains.
Consistent with the earlier observations, transformants expressing
C. reinhardtii or yeast ERG3 ORFs are able to grow on acetate as a
sole carbon source, while the mutants transformed with the empty
vector control cannot grow (Fig. 6C). All strains (Table 3) showed
normal growth on minimal dextrose media minus leucine (Fig. 6D).
Figure 3. Amino acid sequence alignment of Sterol C-5 desaturase in different organisms. Arabidopsis thaliana (AtERG3) NCBI Accession
Number CAA62079; Zea mays (ZmERG3) ACG38774; Chlamydomonas reinhardtii (CrERG3) XP_001701457; Homo sapiens (HsERG3) BAA33729; Rattus
norvegicus (RnERG3) NP_446094; Sacchromyces cerevisiae (ScERG3) NP_013157. Conserved amino acid sequences shared by all organisms are denoted
by a star. The highlighted area corresponds to the putative histidine-containing metal binding domain. Dashed lines indicate gaps in the alignment.
The bold, italicized font corresponds to the three putative transmembrane spanning regions of the C. reinhardtii ERG3 protein.
doi:10.1371/journal.pone.0008659.g003
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qualitative GC/MS analysis was performed to verify the presence
of ergosterol in the complemented yeast transformants. Cultures of
erg3D yeast expressing S. cerevisiae ERG3 or C. reinhardtii ERG3 were
grown to similar cell densities, collected, and lipids were extracted
and derivatized for analyses. Selected ion monitoring for ion 363
of ergosterol was used to search the total ion chromatograph for
ergosterol in the samples (Fig. 7). When analyzing the total ion
chromatograph data for specific ions of ergosterol, the knockout
strain with the vector control was found to have a marked
reduction in the level of ergosterol in the membranes compared to
the strains complemented with the ERG3 ORF from C. reinhardtii
and S. cerevisiae (Fig. 7). Gas chromatography data contained peaks
with retention times for the ergosterol standard, DDY 4263, and
DDY 4261 respectively at 11.46, 11.46, and 11.47 minutes. The
mass ions coinciding with these specific retention times gives
spectral data with ions 468, 363, 337, and 253 m/z as previously
described as ergosterol mass ions by Griffiths et al [36]. These
experiments demonstrate that expression of ERG3 from C.
reinhardtii can restore ergosterol biosynthesis in erg3D yeast.
Discussion
Ergosterol is the major sterol found in membranes of C.
reinhardtii. However, the specific genes involved in sterol biosyn-
thesis in Chlamydomonas have not yet been fully characterized.
Several sterol mutant strains were previously identified in C.
reinhardtii by selecting for resistance to the polyene antibiotic,
nystatin [13,37]. Polyene antibiotics function by forming com-
plexes with the sterols in the membrane and decreasing membrane
selective permeability, thereby causing cell death [38]. This
method of selection was used to identify ergosterol mutants and
allow researchers to delineate the final steps of ergosterol
biosynthesis in C. reinhardtii, namely from ergosta- 7, 24(28)- dienol
or 5- dehydroepisterol to ergosterol (Fig. 1). However, until
recently very little was known about the steps from squalene
epoxide to ergosta- 7, 24(28)-dienol. With the publication of the
Chlamydomonas genome [12], we are now able to identify genes that
may play a role in sterol biosynthesis in C. reinhardtii. Analysis of the
genome indicates that the C. reinhardtii sterol biosynthetic pathway
from squalene epoxide to episterol most closely follows the higher
plant pathway. This means that C. reinhardtii is synthesizing
ergosterol differently than yeast although many of the individual
steps and enzymes are homologous. Yeast genetics allows not only
the study of the function of yeast genes, but is also useful for cross-
species complementation studies, and unlike C. reinhardtii, several
ergosterol mutants have been identified in yeast, and their
phenotypes have been well documented [16,39]. We chose
ERG3 for further study, as specific phenotypes previously
characterized in yeast erg3 mutants are readily complemented.
ERG3 encodes a sterol C-5 desaturase, and belongs to the fatty
acid hydroxylase superfamily. This superfamily of proteins
includes C-5 sterol desaturases as well as C-4 sterol methyl
oxidases [32,40,41]. This family of proteins possesses four putative
iron-binding domains [28]. In yeast, loss of ERG3 function leads to
an apparent loss of ergosterol in the membrane and an increase
in the closely related precursor, episterol. The replacement of
ergosterol with episterol in yeast leads to increased sensitivity to
cycloheximide and an inability to grow with acetate as a sole
carbon source [24]. The efficient gene replacement techniques
used in Sacchromyces cerevisiae, has allowed for the creation of mutant
strains in which the ERG3 gene has been replaced with URA3
[42,43], providing an experimental tool for complementation
studies.
Complementation of yeast knockout strains has been used
successfully to identify genes involved in sterol biosynthesis in
Arabidopsis [20]. The yeast Erg25 (sterol 4a-methyloxidase) [44],
Erg24 (sterol C-14 reductase) [45], Erg2 (D8-D7 sterol isomerase)
[46] and Erg3 [47] mutants have all been complemented by the
corresponding Arabidopsis genes, even though the homology
between the yeast and Arabidopsis proteins was fairly low and the
natural substrate in Arabidopsis differs somewhat from that of the
yeast pathway. These previous results with Arabidopsis suggested
that Chlamydomonas genes encoding homologous proteins might
also be identified by complementation in yeast. In the work
described here we were able to confirm the annotation of the C.
reinhardtii ERG3 ortholog as a C-5 sterol desaturase by both
phenotypic complementation and direct biochemical analysis.
While the C. reinhardtii ERG3 ORF does function in yeast, it
must be noted that it does not complement as fully as the yeast
Figure 4. Schematic diagram of sterol C-5 desaturase in C. reinhardtii as annotated in the JGI Chlamydomonas Genome Version 4.0.
ERG3 has six exons and five introns.
doi:10.1371/journal.pone.0008659.g004
Figure 5. Deletion of the ERG3 gene in yeast. (A) Schematic
diagram of homologous recombination strategy used to delete ERG3 in
Sacchromyces cerevisiae. PCR primers were designed to amplify the
URA3 marker gene containing the flanking regions of ERG3. (B) Ura
+
isolates were screened by PCR to verify proper integration of URA3 and
deletion of ERG3. Only correctly integrated isolates would show a 459
base pair product using primers internal to URA3 and upstream of the
flanking homology. Stars denote the positive isolates selected for
further analysis. PCR was also used to verify the downstream end of
flanking region homology with URA3 (data not shown).
doi:10.1371/journal.pone.0008659.g005
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2 micron plasmids have been used in yeast for heterologous
complementation, in order to increase the copy number of the
plasmid and possibly circumvent issues regarding variations in
protein stability, codon usage, and enzyme activity across species
[48]. This study uses a moderate copy number plasmid. Secondly,
yeast and C. reinhardtii undergo two very different biochemical
pathways for the production of sterols. Yeast use the traditional
MVA (IPP) pathway for the synthesis of sterols, while C. reinhardtii
utilizes the DOXP pathway for the synthesis of sterols [49].
Evolutionary differences across species allow for several variations
in the ergosterol biosynthetic pathway. For example, C. reinhardtii
and S. cerevisiae produce precursors to ergosterol by two inde-
pendent pathways so therefore similar enzymes can often catalyze
somewhat different reactions [27,49]. Finally, ergosterol biosyn-
thesis is a very metabolically taxing process that requires molecular
oxygen, sources of energy, and optimal temperatures [50]. Despite
these potential complications, complementing the yeast ERG3 null
mutation with the ERG3 gene from C. reinhardtii results in the
production of ergosterol, and increased survival of the cells during
exposure to cycloheximide and growth on acetate.
Sterol biosynthesis is very intricate in nature, and while several
ERG3 orthologs from different eukaryotic species have been
identified and characterized, ERG3 mutants in Chlamydomonas have
not been created. Previous studies using random mutagenesis in
Chlamydomonas identified mutants in the last two steps of ergosterol
biosynthesis but not in the earlier steps of sterol biosynthesis, which
includes ERG3. Presently, there are no consistently reliable
methods to knock-out specific genes in Chlamydomonas although
new methods are being developed. While bioinformatics as well as
functional complementation gives insight into the function of a
gene and its corresponding proteins, knockout experiments in the
future will allow for a more complete characterization of the gene,
as a targeted mutation of the gene we have annotated as ERG3
would allow confirmation of the C-5 sterol desaturase activity
observed by complementation in yeast.
Elucidation of the ergosterol biosynthetic pathway in C.
reinhardtii is of considerable interest and importance, as plant and
algal sterols are used as dietary supplements, and as components of
cosmetics and pharmaceuticals [51]. For example, experimental
evidence has shown that uptake of plant sterols can help to reduce
cholesterol levels in humans [52,53]. The similarity of the C.
reinhardtii ERG3 gene with that of higher plants indicates that the
Chlamydomonas system may provide an excellent model system in
which to study plant sterol biosynthesis. Better understanding of
this pathway will lead to the development of genetically modified
strains in Chlamydomonas that may allow for overproduction of
specific ergosterol precursors.
Materials and Methods
Yeast Competent Cell Preparation and Transformation
For complementation experiments, yeast were transformed with
plasmids expressing ERG3 from Chlamydomonas and ERG3 from
yeast using the protocol of Geitz et al [54]. For the construction of
erg3D strains, single yeast colonies were inoculated and grown
overnight. In the morning, cultures were diluted to an optical
Figure 6. Phenotypic complementation of yeast erg3D strains.
Known phenotypes of yeast erg3 null mutants (hypersensitivity to
cycloheximide and inability to grow on acetate) were complemented by
plasmids expressing either S. cerevisiae ERG3 or C. reinhardtii ERG3
cDNA. A) S. cerevisiae ADH1 promoter plasmid used to express ERG3
genes. Haploid yeast carrying the erg3D::URA3 allele were transformed
with the designated plasmids and plated on dextrose minimal media
lacking leucine (YMD minus Leu) to select for transformants. Single
colony isolates were then re-streaked on minimal media lacking leucine
and containing cycloheximide (0.13 mg/mL) (B) minimal media lacking
leucine and containing acetate as sole carbon and energy source (C),
and on YMD lacking as overall growth control (D). Yeast mutant for
ERG3 and containing the vector plasmid lacking an insert cannot grow
on cycloheximide or acetate, while cells containing the plasmid
expressing either yeast or C. reinhardtii ERG3 are able to grow. Each
pair of plates represents erg3D yeast sporulated from two indepen-
dently isolated diploid knockout isolates, 1+2 are DDY4259 and
DDY4260 transformed with the vector only, 3+4 are DDY4261 and
DDY4262, the same strains transformed with ADH1-yeast ERG3, and 5+6
are DDY4263 and DDY4264 with ADH1-C.reinhardtii ERG3. For the
second panel, 7+8 are DDY4253 and DDY4254 transformed with the
vector only, 9+10 are DDY4255 and DDY4256 transformed with ADH1-
yeast ERG3,a n d1 1 +12 are DDY4257 and DDY4258 with ADH1-
C.reinhardtii ERG3.
doi:10.1371/journal.pone.0008659.g006
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approximate optical density of 0.7. Cells were harvested by
centrifugation (20006g for 5 minutes) at room temperature, and
the cell pellet was resuspended in 1 mL of 1xTEL (10 mM Tris-
HCl pH 7.5, 1 mM EDTA pH 8.0, 100 mM LiAc) per 10 mL
culture volume and rocked overnight at room temperature.
Yeast Strains and Growth
Yeast strains were constructed by homologous recombination
using primers 59- TGCATTTGTAAAAAAAGATAAAAGA-
AAAATATTCGTCTAGATTTGAGA TGCAG ATTGTACT-
GAGAGTGC- 39 (forward) and 59- TCTTGAACGTGAAAG-
AAAGAA AAAAGATGAGACAAACAAGGCAACCGTA TC-
TCCTTACGCATCTGTGCGG-39 (reverse) to amplify the
yeast URA3 gene flanked by ERG3 sequence. This PCR product
was transformed into yeast as described above, Ura+ colonies
were isolated, and erg3D isolates verified by PCR analysis. Deletion
of ERG3 was done in DDY2, a diploid version of S. cerevisiae
W303), which was then sporulated to haploid (see below). Yeast
were cultured in YPD (1% yeast extract, 2% peptone, 2%
dextrose) or YMD (synthetic minimal medium, 2% dextrose,
U. S. Biologicals catalog # Y2025) supplemented with required
amino acids and nucleotides [55]. Unless otherwise stated, all
yeast operations were carried out according to standard proce-
dures [56]. To construct an ADH1 promoter vector, the plasmid
pOAD (gift from Dr. Stan Fields, University of Washington)
was modified as follows. The GAL4 coding sequence was
removed by digestion with Hind III, and re-ligated to produce
the ADH1 promoter control vector pDD1193, and ERG3 genes
were coned into the resulting unique Hind III site. Expression
of S. cerevisiae and C. reinhardtii ERG3 cDNA from the ADH1
promoter of yeast expression vector pDD1193 was carried out by
culture of the transformed yeast strain in minimal media lacking
leucine.
Yeast Genomic DNA Extraction
Yeast genomic DNA was extracted by the Winston protocol
[57].
Tetrad Dissection
Heterozygous diploid erg3D::URA3 cells were cultured on YPD
plates, then transferred to spore plates. A colony-sized mass of cells
was re-suspended in 6 mL Zymolase 100T (1 mg/mL, Sigma) for
each sporulation and incubated for 2 minutes at room temperature.
After incubation, 300 mL of water was added to each sample. Each
sample solution was then spread along the upper portion of a petri
dish and tetrads were separated with an Olympus B201 Dissecting
scope. Each plate was incubated at 30uC, and cells were re-patched
toa masterplate.Eachmasterplatewasthen replicaplatedtoYMD
dropout plates and mating tester lawns to determine genotype.
cDNA Cloning
Chlamydomonas Core Library. The Chlamydomonas cDNA core
library was purchased from the Chlamydomonas Center (http://
www.chlamy.org/). The library was amplified using the host strain
XL1 Blue MRF’ (Stratagene catalog number 200301) according to
the manufacturer’s instructions at http://www.stratagene.com/
lit/manuals/aspx (catalog number 236201).
The S. cerevisiae ERG3 protein coding sequence (accession
number NP_013157) was used to identify the C. reinhardtii EST
with the best homology using the BLAST server (http://
genomeportal.jgi-psf.org/Chlre4/Chlre4.home.html). Primers were
designed based on the EST sequence in order to clone the
coding region of cDNA from the core library described above. The
Table 2. Yeast strains used in this work.
Strains Genotype Source
DDY 4259 MAT ADE2 his3 leu2 LYS2 trp1 ura3 erg3D::URA3 pDD1193 This study
DDY 4260 MATa ADE2 his3 leu2 lys2D trp1 ura3 erg3D::URA3 pDD1193 This study
DDY 4253 MAT ADE2 his3 leu2 LYS2 trp1 ura3 erg3D::URA3 pDD1193 This study
DDY 4254 MAT ADE2 his3 leu2 LYS2 trp1 ura3 erg3D::URA3 pDD1193 This study
DDY 4261 MAT ADE2 his3 leu2 LYS2 trp1 ura3 erg3D::URA3 pDD 1192 This study
DDY 4262 MATa ADE2 his3 leu2 lys2D trp1 ura3 erg3D::URA3 pDD1192 This study
DDY 4255 MATa ade2 his3 leu2 lys2D trp1 ura3 erg3D::URA3 pDD1192 This study
DDY 4256 MAT ADE2 his3 leu2 LYS2 trp1 ura3 erg3D::URA3 pDD1192 This study
DDY 4263 MAT ADE2 his3 leu2 LYS2 trp1 ura3 erg3D::URA3 pDD1191 This study
DDY 4264 MATa ADE2 his3 leu2 lys2D trp1 ura3 erg3D::URA3 pDD1191 This study
DDY 4257 MATa ade2 his3 leu2 lys2D trp1 ura3 erg3D::URA3 pDD1191 This study
DDY 4258 MAT ADE2 his3 leu2 LYS2 trp1 ura3 erg3D::URA3 pDD1191 This study
doi:10.1371/journal.pone.0008659.t002
Table 3. Plasmids used in this study.
Plasmid Description Source
pDD 1191 1.1 kb Hind III fragment containing ERG3 open reading frame from C. reinhardtii inserted into pDD 1193 This study
pDD 1192 1.1 kb Hind III fragment containing ERG3 open reading frame from S. cerevisiae inserted into pDD 1193 This study
pDD 1193 LEU2 marked S. cerevisiae ADH1 promoter vector. This study
doi:10.1371/journal.pone.0008659.t003
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primer: 59-GCGGCCGCCGATCGAAGCTTAATGTCAACC-
TCGCTCAAAATGA-39 and the reverse primer: 59-GCGG-
CCGCCGATCGAAGCTTTACTGCGCCTTGACGGCCT-39.
Sequence Analysis
Multiple sequence alignment programs from the European
Bioinfomatics Institute EMBL-EBI server (http://www.ebi.ac.uk/
clustalw/) were used for sequence analysis and alignment data.
The Prosite database from EBI server (http://ca.expasy.org/
prosite/) was used to identify putative consensus motifs for specific
domains in ERG3. The C. reinhardtii genomic database provided
information about the genomic sequence, intron-exon structure of
ERG3, as well as information regarding potential membrane
spanning regions of the protein coding sequence (http://
genomeportal.jgi-psf.org/Chlre4/Chlre4.home.html).
Drug Resistance Screen
Cycloheximide was purchased from Sigma Aldrich (catalog#
C- 7698-1G). S. cerevisiae minimal media was prepared as
previously described with the addition of cycloheximide [34] at
a final concentration of 0.13 mg/mL from a stock solution of
2 mg/ml in 100% ethanol.
Lipid Extraction
Yeast cells were grown to an optical density (A600) of 0.7-0.8. The
cells were pelleted at 2000 rpm for 5 minutes and resuspended in
4 mL hot isopropanol (70uC) for 30 minutes. The cell wall was
Figure 7. GC/MS data. Total ion chromatographs were analyzed to look specifically for the 100% ion of ergosterol. Mass ion 363 gives the best
indication of the presence or absence of ergosterol in the samples. (A) Ergosterol standard, (B) Lipid extract from DDY4259 vector control, (C)
DDY4263 expressing C.reinhardtii ERG3, (D) DDY4261 expressing S. cerevisiae ERG3.
doi:10.1371/journal.pone.0008659.g007
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pellets were then resuspended in 4 mL hot isopropanol and lipids
were extracted at 70uC for 2 hours. Next, 4 mL of chloroform/
methanol (1:2) and 2 mL of 1 M KCL were added to the lipid
extracts, which were vortexed and centrifuged at 5000 rpm on a
benchtop centrifuge for 5 minutes. The top aqueous phase was
discarded and the previous extraction step was repeated three times.
Then, 2 mL of water were then added to the samples. The samples
were vortexed and centrifuged at 5000 rpm for 5 minutes, and the
aqueous phase was discarded again. Lipids were dried under
nitrogen and stored at 280uC until analysis. The lipid extraction
protocol was derived from the Bligh and Dyer method [58].
GC/MS Analysis
Ergosterol standard was purchased from Fluka. N,O-bis(tri-
methylsilyl)trifluoroacetamide (BSTFA) was used as the silylating
reagent and was purchased from Sigma Aldrich (catalog #33084).
100 mL of BSTFA was added to dried lipid samples and heated to
60uC for 30 minutes. Derivatized samples were resuspended in
25 mL of dichloromethane and prepared for analysis. GC/MS was
carried out on an Agilent 6890 gas chromatograph with an
autosampler and Agilent 5973 mass selective detector. Then, 1 mL
of sample was injected into a splitless system with a flow rate of
1 mL/min for the carrier gas, helium. The front inlet temperature
was maintained at 250uC, while the mass selective detector line
heater was at 280uC. The oven temperature was programmed to a
final temperature of 300uC with an initial temperature of 100uC.
The GC column, DB-5 ms, was 30 meters by 250 mm of internal
diameter with a film thickness of 0.25 mm. Data was acquired
by selective ion monitoring to detect ions at m/z 143, 211,337,
363, 468.
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